Milford-based biotech company Waters Corp. will merge with Becton, Dickinson and Co.’s biosciences an diagnostic solutions ...

A deal for Becton Dickinson’s biosciences and diagnostic solutions unit puts Waters Corp. in a greater position to compete ...

Shares of Waters Corp. slid 3.16% to $287.53 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.01% to 6,296.79 and Dow Jones ...

Becton, Dickinson and Company is an attractive firm that just made a good deal. Click here to find out why BDX stock is a Buy ...

Any one of the majors will be thrilled to snap some of these brands because there’s very little organic growth in the ...

BD has reached an agreement to merge its Biosciences & Diagnostic Solutions business with Waters Corporation in a nearly $17.5bn deal.

Waters Corporation is merging with BD’s Biosciences and Diagnostic Solutions business in a $17.5 billion deal to expand its capabilities in life sciences and diagnostics.

Waters Corp.'s $17.5B merger with BD Biosciences aims to double revenue but raises risks. Read here for an investment ...

Waters Corp. closed 29.90% below its 52-week high of $423.56, which the company reached on January 30th.

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Shares of Waters Corp. closed Tuesday at $326.93, up $24.55 (8.1%), in New York Stock Exchange trading. More than 826,000 shares exchanged hands, more than twice the stock's usual volume.

Shares of Waters Corp. WAT slid 0.21% to $267.48 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 0.14% to 4,191.98 and Dow ...